Valganciclovir
11 NDCs across 9 manufacturers|11 Generic,0 Brand
Valganciclovir is used to treat aids-related opportunistic infections and cytomegalovirus retinitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Valganciclovir is available as 11 NDCs from 9 manufacturers (11 generic, 0 brand), with NADAC prices from $1.91 to $1.91 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
11
11G / 0B
Manufacturers
9
competing in market
Price Spread
$1.91 – $1.91
per EA, 8 of 11 NDCs
7d Activity
avg -3.6% WoW · of 11 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Major Pharmaceuticals manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
9 manufacturers producing VALGANCICLOVIR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VALGANCICLOVIR 450 MG TABLET | $1.9150 per EA | -4.97% |
VALGANCICLOVIR 450 MG TABLET | $1.9150 per EA | -4.97% |
VALGANCICLOVIR 450 MG TABLET | $1.9150 per EA | -4.97% |
VALGANCICLOVIR 450 MG TABLET | $1.9150 per EA | -4.97% |
VALGANCICLOVIR 450 MG TABLET | $1.9150 per EA | -4.97% |
VALGANCICLOVIR 450 MG TABLET | $1.9150 per EA | -4.97% |
VALGANCICLOVIR 450 MG TABLET | $1.9150 per EA | -4.97% |
VALGANCICLOVIR 450 MG TABLET | $1.9150 per EA | -4.97% |
VALGANCICLOVIR HCL 50 MG/ML | $1.0058 per ML | +1.62% |
VALGANCICLOVIR HCL 50 MG/ML | $1.0058 per ML | +1.62% |
VALGANCICLOVIR HCL 50 MG/ML | $1.0058 per ML | +1.62% |
Frequently Asked Questions
What is Valganciclovir used to treat?
Valganciclovir is used to treat aids-related opportunistic infections and cytomegalovirus retinitis, per the National Library of Medicine's MED-RT classification.
How many Valganciclovir products are on the market?
The Valganciclovir drug market contains 11 NDCs from 9 manufacturers — 11 generic and 0 brand products.
What is the price range for Valganciclovir?
NADAC reference prices for Valganciclovir range from $1.9150 to $1.9150 per EA. 3 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Valganciclovir?
9 manufacturers list Valganciclovir in NADAC. Ranked by number of NDCs, the largest are Major Pharmaceuticals (2), American Health Packaging (2), Ajanta Pharma USA Inc. (1), Camber Pharmaceuticals Inc. (1), AvPAK (1).
How has the price of Valganciclovir changed recently?
Over the past 7 days, 4 Valganciclovir NDCs rose and 16 fell, with a market-wide average change of -3.6%.